Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"Diabetes, obesity & metabolism"
topic_facet:"Glycated Hemoglobin A"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Glycated+Hemoglobin+A%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
/vufind/Search/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Glycated+Hemoglobin+A%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=journalStr%3A%22Diabetes%2C+obesity+%26+metabolism%22&filter%5B%5D=topic_facet%3A%22Glycated+Hemoglobin+A%22&lookfor=%22Clinical+Trial%2C+Phase+III%22&type=Subject
PubPharm (141)
1
Efficacy and safety of DBPR108 (prusogliptin) as an add-on to metformin therapy in patients with type 2 diabetes : A 24-week, multi-centre, randomized, double-blind, placebo-controlled, superiority, phase III clinical trial
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Xu, J.
|
Ling, H.
|
Geng, J.
| +8
Wird geladen...
2
Effect of once-weekly semaglutide versus thrice-daily insulin aspart, both as add-on to metformin and optimized insulin glargine treatment in participants with type 2 diabetes (SUSTAIN 11) : A randomized, open-label, multinational, phase 3b trial
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Kellerer, M.
|
Kaltoft, M.
|
Lawson, J.
| +4
Wird geladen...
3
Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Wang, W.
|
Song, X.
|
Lou, Y.
| +3
Wird geladen...
4
Efficacy and safety of imeglimin add-on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3) : A randomized, double-blind, placebo-controlled phase 3 trial with a 36-week open-label extension period
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Reilhac, C.
|
Dubourg, J.
|
Thang, C.
| +3
Wird geladen...
5
Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes : Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudy
enthalten in:
Diabetes, obesity & metabolism
| 2022
von
Frías, J.
|
Maaske, J.
|
Suchower, L.
| +4
Wird geladen...
6
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Dejgaard, T.
|
von Scholten, B.
|
Christiansen, E.
| +6
ErratumIn: Diabetes Obes Metab. 2022 Nov;24(11):2280. - PMID 36004610
Wird geladen...
7
Comparable efficacy and safety between LY2963016 insulin glargine and insulin glargine (Lantus®) in Chinese patients with type 1 diabetes : A phase III, randomized, controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Yan, X.
|
Jiang, S.
|
Lou, Y.
| +1
Wird geladen...
8
Henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin : A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Weng, J.
|
Zeng, L.
|
Zhang, Y.
| +14
Wird geladen...
9
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes : Design and baseline characteristics of the SoliMix randomized controlled trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
McCrimmon, R.
|
Al Sifri, S.
|
Emral, R.
| +11
ErratumIn: Diabetes Obes Metab. 2021 Nov;23(11):2600. - PMID 34463418
Wird geladen...
10
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise : A randomized, double-blind, placebo-controlled, phase 3 trial
enthalten in:
Diabetes, obesity & metabolism
| 2021
von
Lu, J.
|
Fu, L.
|
Li, Y.
| +16
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Zeitschrift: Diabetes, obesity & metabolism
Filter aufheben
Thema: Glycated Hemoglobin A
Medienart
141
Aufsätze
141
E-Artikel
141
E-Ressourcen
Zeitschriftentitel
Diabetes, obesity & metabolism
Thema
141
Clinical Trial, Phase III
Glycated Hemoglobin A
139
Journal Article
139
Randomized Controlled Trial
119
Research Support, Non-U.S. Gov't
117
Hypoglycemic Agents
100
Blood Glucose
99
Multicenter Study
86
hemoglobin A1c protein, human
78
type 2 diabetes
53
9100L32L2N
53
Metformin
36
2ZM8CX04RZ
36
Insulin Glargine
31
Comparative Study
26
glycaemic control
23
Dipeptidyl-Peptidase IV Inhibitors
23
Sulfonylurea Compounds
22
Glucosides
21
phase III study
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
19
2020-
122
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
141
Englisch
Haven't found what you're looking for?
Wird geladen...